Ann: First US Surgeon Podium presentations of Novosorb BTM, page-14

"Dr Hamed Amani, Lehigh Valley Hospital, presented on limb salvage; diabetic foot ulcers, electrical burn and flame burn. In all of these cases the outcomes were outstanding. Dr Amani was fully expecting the NovoSorb BTM to fail in the limb salvage case due to the poor state of the wound bed and the underlying condition of the patient and yet the NovoSorb BTM worked and the patient retained his leg and is walking today."

This is what other treatments are doing. This patient had 6 applications to achieve wound closure after 7 weeks. Polynovo BTM would blow this out of the water on cost alone.

This is the preamble of the webinar

Summary
Presented by Dan Davis, DPM (see bio below)
Chronic wounds, or wounds that fail to proceed through an orderly and timely repair process, affect some 6.5 million patients in the United States with an associated cost of care over $50 billion annually.^1,2 These ailments can require lengthy treatments at significant costs to the healthcare system. Major disability, poor quality of life, and reduced productivity contribute to the growing financial burden.^1-3 The number of people affected by a chronic wound is expected to increase as the population ages and the incidence of diabetes and obesity continues to rise worldwide.^1,5Wound duration is an independent risk factor for infection, hospitalization, and amputation, and contributes to patient morbidity, mortality, and cost of care.<sup>5

https://event.on24.com/eventRegistr...0D9504A0CE7&regTag=&sourcepage=register[/sup]</sup>

	Column 1
0	Column 1 0

	Column 1
0	Column 1 0 Column 1 0 YOUR NATURAL CHOICEfor wound careGrafix® is a viable cryopreserved placental membrane comprised of an extracelluar matrix rich in collagen, growth factors, and living cells (including mesenchymal stem cells).

[/table][/table]

Column 1

0

CASE STUDY*:COMPLEX DIABETIC FOOT WOUND/SURGICAL DEHISCENCE Column 1 0 Column 1 0 Patient & Diagnosis: 39-year-old male with complex diabetic foot wound status post surgical dehiscence of right 4th ray amputation site.Prior Treatment: NPWT and wet to dry dressingsWound Treatment and Outcome: In addition to standard of care, 6 serial applications of Grafix achieved complete wound closure by week 7.

	Column 1
0	*Case study results may not be indicative of clinical outcome.

	Column 1
0	Column 1 0 Click here for more information about Grafix® →

[/table][/table][/table]

	Column 1
0	Column 1 0 Column 1 0

	Column 1
0	Column 1 0 On-Demand Webinar:

	Column 1
0	Clinical and Scientific Advances in the Use of Placental Membranes

	Column 1
0	Speaker: Dr. Dan Davis

	Column 1
0	Program: A 45-minute presentation followed by a 15-minute recorded Q&A session

[/table][/table]

	Column 1
0	Column 1 0 Objectives for this webinar: Describe the science of placental membranes and their relevance in chronic and complex wounds Review published clinical study results on the use of placental membranes in complex wounds with exposed bone and tendons Explore clinical case studies on the use of placental membranes in a variety of chronic and complex wounds

	Column 1
0	Column 1 0 Watch the webinar now →

[/table][/table][/table][/table]